Board Member And Investor
CurrentTraining with the product IQoro (1.5 minutes per day) treats orofacial disorders such as dysphagia, hiatus hernia, GERD symptoms and snoring/apnoea. Study examples: 71% of patients with brain-damage dysphagia get sustainable normalized swallowing capacity (97% have a significant improvement); 100% of hiatus hernia patients become significantly improved (between 53-74% are totally symptom free, depending on the symptom).MYoroface is already growing fast and profitably, mainly in the B2C channel, and has just commenced its international expansion.